ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för Tariquidar. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

50 träffar

Bibliografisk träff 2013-11-12

Optimization of novel indole-2-carboxamide inhibitors of neurotropic alphavirus replication.

Sindac JA, Barraza SJ, Dobry CJ, Xiang J, Blakely PK, Irani DN, Keep RF, Miller DJ, Larsen SD.

J Med Chem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm401330r

Bibliografisk träff 2013-03-04

Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.

Ochoa-Puentes C, Bauer S, Kühnle M, Bernhardt G, Buschauer A, König B.

ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/ml4000832

Bibliografisk träff 2013-01-05

Potent and selective tariquidar bioisosters as potential PET radiotracers for imaging P-gp.

Contino M, Zinzi L, Perrone MG, Leopoldo M, Berardi F, Perrone R, Colabufo NA.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2012.12.084

Bibliografisk träff 2012-03-27

Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein.

Jabeen I, Pleban K, Rinner U, Chiba P, Ecker GF.

J Med Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1021/jm201705f

Tillbakadragen publikation 2011-06-24

Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin.

Goldsborough AS, Handley MD, Dulcey AE, Pluchino KM, Kannan P, Brimacombe KR, Hall MD, Griffiths G, Gottesman MM.

J Med Chem · retracted publication; research support, n.i.h., intramural; research-article; journal article · DOI 10.1021/jm2001663

Bibliografisk träff 2011-04-28

Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).

Puentes CO, Höcherl P, Kühnle M, Bauer S, Bürger K, Bernhardt G, Buschauer A, König B.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2011.04.094

Bibliografisk träff 2010-12-30

Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).

Pick A, Müller H, Mayer R, Haenisch B, Pajeva IK, Weigt M, Bönisch H, Müller CE, Wiese M.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2010.12.043

Bibliografisk träff 2010-06-22

Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor.

Bauer F, Kuntner C, Bankstahl JP, Wanek T, Bankstahl M, Stanek J, Mairinger S, Dörner B, Löscher W, Müller M, Erker T, Langer O.

Bioorg Med Chem · research support, non-u.s. gov't; research-article; journal article · DOI 10.1016/j.bmc.2010.06.057

Bibliografisk träff 2010-03-01

Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials.

Colabufo NA, Berardi F, Cantore M, Contino M, Inglese C, Niso M, Perrone R.

J Med Chem · review; journal article · DOI 10.1021/jm900743c

Bibliografisk träff 2010-03-01

Membrane transporters in drug development.

International Transporter Consortium, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L.

Nat Rev Drug Discov · research-article; review; research support, u.s. gov't, non-p.h.s.; journal article; research support, n.i.h., extramural · DOI 10.1038/nrd3028

Bibliografisk träff 2009-11-10

Novel lead for potent inhibitors of breast cancer resistance protein (BCRP).

Pick A, Müller H, Wiese M.

Bioorg Med Chem Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmcl.2009.11.004

Bibliografisk träff 2009-02-05

Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators.

Klinkhammer W, Müller H, Globisch C, Pajeva IK, Wiese M.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2009.01.072

Bibliografisk träff 2009-02-01

Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.

Kühnle M, Egger M, Müller C, Mahringer A, Bernhardt G, Fricker G, König B, Buschauer A.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm8013822

Bibliografisk träff 2008-07-20

Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2).

Pick A, Müller H, Wiese M.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2008.07.034

Bibliografisk träff 2007-11-28

Functional assay and structure-activity relationships of new third-generation P-glycoprotein inhibitors.

Müller H, Pajeva IK, Globisch C, Wiese M.

Bioorg Med Chem · research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1016/j.bmc.2007.11.057

Bibliografisk träff 2007-03-12

In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2).

Labrie P, Maddaford SP, Lacroix J, Catalano C, Lee DK, Rakhit S, Gaudreault RC.

Bioorg Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bmc.2007.03.014

Bibliografisk träff 2006-10-10

Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.

Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W.

Neuropharmacology · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuropharm.2006.07.038

Bibliografisk träff 2004-10-01

Ex vivo reversal of chemoresistance by tariquidar (XR9576).

Di Nicolantonio F, Knight LA, Glaysher S, Whitehouse PA, Mercer SJ, Sharma S, Mills L, Prin A, Johnson P, Charlton PA, Norris D, Cree IA.

Anticancer Drugs · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1097/00001813-200410000-00006

Bibliografisk träff 2004-03-01

Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.

Walker J, Martin C, Callaghan R.

Eur J Cancer · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejca.2003.09.036

Bibliografisk träff 1999-02-01

Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives.

Roe M, Folkes A, Ashworth P, Brumwell J, Chima L, Hunjan S, Pretswell I, Dangerfield W, Ryder H, Charlton P.

Bioorg Med Chem Lett · journal article · DOI 10.1016/s0960-894x(99)00030-x